Association Briefs

Clinical Ecology: Irritant or Cure? An American College of Physicians committee seems to have had an allergic reaction to clinical ecology, a field of research based on the contention that certain people are sensitive to synthetic chemicals at very low doses. According to the committee, which published its review in the July 15 issue of Annals of Internal Medicine, clinical ecology lacks “definition,” uses “procedures of no proven efficacy,” and conducts studies that ar

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

An American College of Physicians committee seems to have had an allergic reaction to clinical ecology, a field of research based on the contention that certain people are sensitive to synthetic chemicals at very low doses. According to the committee, which published its review in the July 15 issue of Annals of Internal Medicine, clinical ecology lacks “definition,” uses “procedures of no proven efficacy,” and conducts studies that are “seriously flawed.” Abba Terr, principal author of the paper, says “people have given up their homes and families have broken up” because of the recommendations of clinical ecologists. Terr also points out that what clinical ecologists treat as an allergy may be another, potentially more serious illness.

Lacrosse, Wis., clinical ecologist David L. Morris says that the paper is focused too much on the "reactions of a few individuals” who have “an ax to grind.” Morris, who reports that 93% of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies